Could new imaging probes spot breast cancer more accurately?

NCT ID NCT06715826

Recruiting now Diagnosis Sponsor: RenJi Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests two new radioactive imaging probes that target specific markers on breast cancer cells. Researchers will use PET/CT scans to see how well these probes find tumors and their spread in 200 women with breast cancer. The goal is to improve diagnosis and help guide treatment decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: [18F]F-RESCA-RT4 and [18F]F-RESCA-RB14 (radioactive imaging probes)
What this could lead to: If successful, these probes could provide a more accurate way to detect breast cancer and its spread, helping doctors choose the right treatments.
What could go wrong: This is an early-phase study with only 200 participants, so results may not apply to all patients. The probes are experimental and may not prove better than current imaging methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER BREAST CANCER, METASTATIC BREAST NEOPLASMS

Contacts and locations

Locations

Renji Hospital, School of Medicine, Shanghai Jiao Tong University
RECRUITING

Shanghai, Shanghai Municipality, 200127, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.